Patients with Glanzmann thrombasthenia lacking platelet glycoprotein αIIbβ3 (GPIIb/IIIa) and αvβ3 receptors are not protected from atherosclerosis

Circulation

Volumn 105, Issue 9, 2002, Pages 1044-1048

  Shpilberg, O ^a   Rabi, I ^a   Schiller, K ^a   Walden, R ^a   Harats, D ^a   Tyrrell, K S ^a   Coller, B ^a   Seligsohn, Uri ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Carotid arteries; Imaging; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLANZMANN DISEASE; HIGH RISK POPULATION; HUMAN; INTERVIEW; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING TEST;

AGED; APOLIPOPROTEINS E; CAROTID ARTERIES; CAROTID ARTERY DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOMOZYGOTE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, VITRONECTIN; REFERENCE VALUES; RISK FACTORS; THROMBASTHENIA;

EID: 0037022915     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0902.104676     Document Type: Article

References (35)

1. Platelet function inhibitors in the year 2000
2. Anti-GPIIb/IIIa drugs: Current strategies and future directions
3. The pathogenesis of atherosclerosis
4. The pathogenesis of atherosclerosis: An update
5. Platelets and atherosclerosis
6. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress
7. New mechanism for foam cell generation in atherosclerotic lesions
8. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
9. Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel
10. Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder
11. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel
12. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: Comparison of techniques for carrier detection
13. Subclinical disease as an independent risk factor for cardiovascular disease
14. Coronary artery calcification in older adults with minimal clinical or subclinical cardiovascular disease
15. Measurement variability in duplex scan assessment of carotid atherosclerosis
16. Atherosclerosis of the carotid arteries documented by Duplex scan as a predictor of coronary artery disease in familial hyperlipidemia
17. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
18. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
19. Noninvasive quantification of atherosclerotic lesions: Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size
20. Ultrasound-determined intima-media thickness and atherosclerosis: Direct and indirect validation
21. Wall thickening of carotid and femoral arteries in male subjects with isolate hypercholesterolemia: PCVMETRA group: Prevention Cardio-Vasculaire en Medecine du Travail
22. Reproducibility of carotid vessel thickness measurements: The Rotterdam study
23. Determinants of carotid intima-media thickness: A population-based ultrasonography study in Eastern Finish men
24. Atherosclerotic lesions: Natural history, risk factors and topography
25. Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries: Statistical analysis from the Oslo study
26. Glanzmann thrombasthenia in two Iraqi-Jewish siblings caused by a novel splice junction mutation in the glycoprotein IIb
27. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentration in healthy subjects
28. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
29. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes
30. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound
31. Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: Evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation
32. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
33. Stimulation of migration of human aortic smooth muscle cells by vitronectin: Implications for atherosclerosis
34. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery
35. Decreased coagulability has no clinically relevant effect on atherogenesis: Observations in individuals with a hereditary bleeding tendency